Skip to main content

ORIGINAL RESEARCH article

Front. Neurosci., 12 October 2023
Sec. Neuropharmacology
This article is part of the Research Topic Plant-Derived Natural Products: Towards Novel Interventions for Neurodegenerative Diseases View all 8 articles

Bioactive strawberry fruit (Arbutus unedo L.) extract remedies paraquat-induced neurotoxicity in the offspring prenatally exposed rats

\r\nZakaria Ait Lhaj
Zakaria Ait Lhaj1*Hind IborkHind Ibork1Sara El IdrissiSara El Idrissi1Farida Ait LhajFarida Ait Lhaj2Mansour SobehMansour Sobeh3Wael M. Y. MohamedWael M. Y. Mohamed4Meryem AlamyMeryem Alamy1Khalid TaghzoutiKhalid Taghzouti1Oualid Abboussi
Oualid Abboussi1*
  • 1Physiology and Physiopathology Team, Faculty of Sciences, Genomic of Human Pathologies Research Centre, Mohammed V University, Rabat, Morocco
  • 2Laboratory of Nanomaterials, Nanotechnologies and Environment, Faculty of Sciences, Center of Materials, Mohammed V University, Rabat, Morocco
  • 3AgroBiosciences Research Division, Mohammed VI Polytechnic University, Ben-Guerir, Morocco
  • 4Basic Medical Science Department, Kulliyyah of Medicine, International Islamic University Malaysia, Kuantan, Pahang, Malaysia

Background: Paraquat (1,1′-dimethyl-4-4′-bipyridinium dichloride) exposure is well-established as a neurotoxic agent capable of causing neurological deficits in offspring. This study aimed to investigate therapeutic effects of Arbutus unedo L. aqueous extract (AU) against paraquat (PQ) exposure.

Methods: For that the phytoconstituents of AU was determined by LC/MS, and then its antioxidant potential was assessed by DPPH and ABTS assays. The assessment included its impact on cell viability and mitochondrial metabolism using N27 dopaminergic cells. Additionally, we evaluated the effects of prenatal PQ exposure on motor coordination, dopamine levels, trace element levels, and total antioxidant capacity (TAC) in rat progeny.

Results: The phytochemical profile of AU extract revealed the presence of 35 compounds, primarily phenolic and organic acids, and flavonoids. This accounted for its strong in vitro antioxidant activities against DPPH and ABTS radicals, surpassing the activities of vitamin C. Our findings demonstrated that AU effectively inhibited PQ-induced loss of N27 rat dopaminergic neural cells and significantly enhanced their mitochondrial respiration. Furthermore, daily post-treatment with AU during the 21 days of the rat's pregnancy alleviated PQ-induced motor deficits and akinesia in rat progeny. These effects inhibited dopamine depletion and reduced iron levels in the striatal tissues. The observed outcomes appeared to be mediated by the robust antioxidant activity of AU, effectively counteracting the PQ-induced decrease in TAC in the blood plasma of rat progeny. These effects could be attributed to the bioactive compounds present in AU, including phenolic acids such as gallic acid and flavonoids such as quercetin, rutin, apigenin, glucuronide, and kaempferol, all known for their potent antioxidant capacity.

Discussion: In conclusion, this preclinical study provided the first evidence of the therapeutic potential of AU extract against PQ-induced neurotoxicity. These findings emphasize the need for further exploration of the clinical applicability of AU in mitigating neurotoxin-induced brain damage.

1. Introduction

Paraquat (PQ) is extensively employed as an herbicide in agricultural practices and has been found to pose detrimental effects on dopaminergic neurons. These effects are primarily attributed to oxidative stress-mediated damage inflicted on lipids, proteins, DNA, and RNA. The process involves the generation of reactive oxygen species (ROS), including superoxide radicals, hydroxyl radicals, and hydrogen peroxide (Colle and Farina, 2021). Notably, PQ-induced neurotoxicity operates via a distinct mechanism compared to that of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). PQ generates ROS within cells through redox cycling, while MPPT-induced neurodegeneration encompasses additional mechanisms (Choukairi et al., 2015). PQ-induced oxidative stress can have detrimental effects on mitochondria, leading to damage and dysfunction. This impairs the ability of dopaminergic neurons to produce adenosine triphosphate (ATP) and meet their metabolic demands (Somayajulu-Nitu et al., 2009; Chaouhan et al., 2022). Consequently, mitochondrial dysfunction and energy deficits play a significant role in the degeneration of dopaminergic neurons and the manifestation of Parkinson's disease (PD)-like behavior (Moradi Vastegani et al., 2023). Moreover, PD prominently affects striatal dopamine, leading to motor impairments due to the loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) (Gerfen, 2000; Smith and Villalba, 2008; Lima, 2013; Huh et al., 2022). Enzymes such as tyrosine hydroxylase (TH) and aromatic L-amino acid decarboxylase (L-DOPA) are involved in dopamine metabolism as their distribution contributes to dopamine level imbalances and motor dysfunction (Lipski et al., 2011; Alrashidi, 2022). Preclinical studies have shown that PQ administration leads to reduced motor activity and a dose-dependent loss of striatal TH-positive neurons (Colle and Farina, 2021; Sun et al., 2023). In addition to dopamine dysregulation, trace element levels in the striatum play a crucial role in neurological diseases such as PD, for example, an imbalance in iron, copper, zinc, and manganese homeostasis can lead to oxidative stress and neurotoxicity (Fukushima et al., 2011; Stelmashook et al., 2014; Bjorklund et al., 2018; Vuuren et al., 2020).

In addition to the well-documented detrimental effects of PQ exposure, there is evidence of prenatal exposure to PQ as it readily crosses the placenta (Berry et al., 2010). This may increase the risk of developmental or post-developmental effects in rodent offspring, including neurobehavioral changes, alterations in dopamine metabolism, and cognitive dysfunction (Chakrabarti, 2015; Ait-Bali et al., 2016). The detrimental effects of PQ on dopaminergic neurons, striatal dopamine metabolism, mitochondrial function, and trace element dysregulation in neurological disorders highlight the need for therapeutic interventions. In this respect, antioxidant compounds, selenium compounds (e.g., ebselen or diphenyl diselenide), and metal chelators are commonly utilized to treat these disorders. However, some of them displayed negative side effects. On the other hand, plant extracts and their phytochemical constituents are highly effective in the treatment of several neurological conditions (Aruoma et al., 2003; Sapkota et al., 2010; Beppe et al., 2014; Solayman et al., 2016). Arbutus unedo L. (A. unedo), also known as a strawberry tree, belongs to the Ericaceae family, and it is widely distributed in the Mediterranean region (Carral, 2015). In Morocco, A. unedo is growing wild in different bioclimatic zones and is used in traditional medicine. It was recently reported that A. unedo fruits provided a rich nutritional value and contained health-promoting components providing almost 42% of the recommended daily allowance (RDA) for fiber and 36% for zinc as well as iron and manganese (Ait Lhaj et al., 2021a). Alongside this higher nutritional potential, these fruits are of great scientific interest due to their several pharmacological effects, such as depurative, hemostatic, anti-inflammatory, antioxidant, antitumor, and neuroprotective (Fortalezas et al., 2010; Šic Žlabur et al., 2020; Tenuta et al., 2020). However, there are no deep scientific studies about the effect of this fruit against neurodegenerative diseases, except the study suggests the potential effect of A. unedo extract fruit against neurodegenerative diseases due to the presence of several flavonoids and phenolic acids (Nunes and Carvalho, 2017). In this context, the study aims to investigate the therapeutic effects of A. unedo extract (AU) in the context of PQ-induced neurotoxicity. The investigation includes studying its effects on dopaminergic neuronal cells as well as in offspring prenatally exposed to PQ. By examining the effects of AU on dopamine levels, dopamine metabolism, striatal trace element levels, and mitochondrial function, this study will provide valuable insights into the potential mechanisms underlying its therapeutic actions. Understanding the interplay between AU extract, striatal dopamine, mitochondrial metabolism, and trace element homeostasis may contribute to the development of novel therapeutic strategies for neurodegenerative disorders.

2. Materials and methods

2.1. Plant material and preparation procedure

Fruits of the wild A. unedo were harvested from the northwest of Morocco (Chefchaouen region), after identification by Pr. Hamid Khamar at the National Scientific Institute of Rabat (Department of Botany and Plant Ecology); a voucher specimen was deposited in the National Herbarium of Scientific Institute of Rabat and registered under the number code RAB111500. The fruits were lyophilized, then ground to obtain a fine powder, and stored in a deep freezer at −20°C for subsequent analyses. The aqueous extract of fruits was prepared by maceration according to the method described by Pinheiro et al. (2020) with a slight modification. Briefly, 100 g of the lyophilized powder is homogenized with 1,000 ml of distilled water under magnetic stirring at room temperature for 24 h. The extract was filtered through a Whatman No. 4 filter paper, lyophilized, and then stored in the dark at −20°C until use (Ait Lhaj et al., 2021b).

2.2. HPLC-PDA-MS/MS analysis

A SHIMADZU LC-MS 8050 (Shimadzu, Japan, USA) LC system equipped with a triple quadrupole spectrometer and an ESI source was used for the phytochemical analysis. The chromatographic and mass spectrometric conditions were similar to those previously described by Tawfeek et al. (2023).

2.3. Antioxidant activity

2.3.1. DPPH radical scavenging assay

The capacity to scavenge diphenylpicrylhydrazyl radical (DPPH·) was monitored according to a method reported before (Ghareeb et al., 2018). Briefly, 200 μl of AU extract (5.25–105 μg/ml) was added to 1.8 ml of a DPPH (0.2 mM) methanolic solution. The mixture was shaken vigorously and left standing at room temperature for 30 min in the dark. The reduction of the DPPH radical was measured at 517 nm vs. a blank solution by using a UV/Vis spectrometer. The DPPH· scavenging activity was calculated by using the equation:

% Scavenging effect = 100 × (A0 -A1)/A0,

where A0 is the absorbance value of the DPPH blank sample and A1 is the absorbance value of the test solution.

2.3.2. ABTS cation radical scavenging assay

The scavenging activity of AU extract against ABTS [2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)] radicals was monitored according to the method described by Arnao et al. (2001). Briefly, 200 μl of AU extract (5.25–105 μg/ml) was added to 2 ml of the ABTS+ working solution, prepared with ABTS (7 mM) and potassium persulfate (2.45 mM), incubated, and diluted with ethanol to achieve an absorbance of 0.70 ± 0.02 at 734 nm before analysis. The mixture was dark-incubated for 30 min at room temperature, and the absorbance was measured at 734 nm compared to a blank solution by using a UV/Vis spectrometer. The ABTS+ scavenging activity was calculated by using the following equation:

% Scavenging effect = 100 × (A0 A1)/A0,

where A0 is the absorbance value of the ABTS+ blank sample and A1 is the absorbance value of the reaction mixture.

The antioxidant activity of freshly prepared aqueous solutions of ascorbic acid (vitamin C, within a range of 0.5–10 μg/ml) was also evaluated against DPPH and ABTS-free radicals. It served as a reference antioxidant for comparing the antioxidant activity of AU extract.

2.4. Biological evaluation

2.4.1. Experimental approach

2.4.1.1. Cell line

To investigate whether PQ may affect specifically the dopaminergic neurons by inducing mitochondrial metabolic alterations, we evaluated its effect on an established N27 rat dopaminergic neural cell line (SCC048 Sigma-Aldrich).

2.4.1.2. Animals

Female and male Wistar rats were sourced from the animal facility at the University of Mohammed V in Rabat. They were housed in a controlled environment with a 12-h light/dark cycle and provided with standard food pellets and unlimited access to water. All experimental procedures were conducted following the guidelines and approval of the University of Mohammed V Animal Ethics Research Committee under the ethical approval number MAM5 70-8647.

For the study, female rats weighing between 180 and 200 g were paired with male rats at a ratio of 2:1. Each morning, the female rats were examined for the presence of vaginal plugs, which indicated successful mating and marked the beginning of gestational day 1 (GND 1). In cases where no vaginal plug was found, vaginal smears were collected and examined for the presence of sperm, thus confirming pregnancy.

2.4.1.3. PQ treatment

A liquid commercial form of PQ Gramoxone (Syngenta Crop Protection, USA) was utilized. This formulation contained a PQ concentration of 200 g/l (Fernandes et al., 2021).

A total of 32 pregnant females were included in the study, with each group consisting of 8 females. They were administered different substances orally through gavage. The substances administered were saline, PQ at a dosage of 20 mg/kg, or AU at a dosage of 1 g/kg. This administration was performed once a day throughout the entire pregnancy period (21 days) from GND 1 to GND 21 according to the following protocol illustrated in Figure 1:

- The control group (Sal/Sal) received saline solution.

- The PQ group (PQ/Sal) was orally administered with PQ dichloride prepared in saline.

- The PQ/AU group was orally administered with AU 2 h after the oral administration of PQ.

- The Sal/AU group was orally administered with AU prepared in saline.

FIGURE 1
www.frontiersin.org

Figure 1. Timeline of the experimental protocol.

Following birth, pups remained with their dams until the post-natal day 21 (PND 21) after which they were culled to female offspring only.

2.4.2. Cell viability test by MTT assay

The N27 rat dopaminergic neural cells viability was assessed using 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT). The dopaminergic cells were plated in 96 well plates at a density of 4 × 104 cells per well and treated for 24 h with saline 0.9%, PQ (10, 100, 250, and 500 μM), AU (10, 100, 1,000, 5,000, and 10,000 μg/ml), or PQ/AU combination at 250 μM and 1,000 μg/ml or 5,000, respectively. Cultures were sustained in an incubator at 37°C for 4 h in the medium containing 0.5 mg/ml MTT. After washing with PBS, absorbance was measured at 490 nm using the Molecular Devices FlexStation II microplate reader.

2.4.3. Mitochondrial metabolic analysis

The cells were maintained at 37°C and 5% CO2 on petri dishes in high glucose DMEM supplemented with 10% FCS, 3.75 mM glutamine, and 2.5 μg/ml fungizone (all Invitrogen). The dishes with the highest density of confluent cells were expanded (1:5), and their mitochondrial respiratory activity was assessed using the Mito stress test.

The metabolic rate of cultured N27 rat dopaminergic neural cells was determined by oxygen consumption rate (OCR) as a measure of mitochondrial function using the Seahorse Metabolic Bioanalyzer XFe24 (Agilent, UK). Oxidative metabolism of cells treated for 4 h with saline, PQ (250 μM), AU (5,000 μg/ml), or both was determined using the Mito stress test as per the manufacturer's instructions (Agilent). Briefly, the cells were stimulated by oligomycin (0.5 μM), carbonyl cyanide-4 (trifluoromethoxy) phenylhydrazone and oxidative phosphorylation uncoupler (FCCP; 1 μM), and rotenone (R) with antimycin A (A), a respiratory complex III inhibitor (R/A; 0.5 μM). All the reagents were dissolved in the Seahorse XF DMEM medium (pH 7.4; Agilent) supplemented with L-glutamine (2 mM), glucose (2.5 mM), and sodium pyruvate (2.5 mM). The mitochondrial respiratory parameters, including basal respiration, ATP production, proton leak, maximal respiration, spare capacity, and coupling efficiency were calculated and evaluated according to the manufacturer's recommendations.

2.4.4. Behavioral analysis for the progeny rats

2.4.4.1. The forelimb akinesia test

The test used to assess motor initiation, known as the forelimb akinesia test, was conducted according to previously described methods (Bonaccorso Marinelli et al., 2017). In summary, the rats were suspended in mid-air, allowing their body weight to rest on the forelimb being tested. Subsequently, each rat was propelled forward on an uneven surface, and the length of the adjusting step taken by the forelimb was measured using an adjacent ruler. Three trials were conducted for each forelimb, and an average step length was calculated for each limb.

2.4.4.2. The limb-use asymmetry test

The limb-use asymmetry (cylinder) test, which evaluates the percentage of forelimb usage during exploratory behavior, was performed as described in studies (Meredith and Kang, 2006; Mabandla and Russell, 2010). Each animal was placed inside a transparent plexiglass cylinder measuring 20 cm in diameter and 30 cm in height for 5 min. The animal's behavior was recorded on video and later analyzed to determine the extent of wall exploration, contact with the wall, and landing after wall contact for both forelimbs. The percentage of limb use was then calculated using the following formula:

                                   % Forelimb use =number of contacts with contralateral limb+1/2 bothipsilateral limb use+ contralateral limb use+ bothX100.

2.4.5. Tissue and blood collection

The offspring rats were euthanized through decapitation on PND 75, and blood samples were collected from their trunks into EDTA tubes. Blood plasma was acquired for the evaluation of total antioxidant capacity (TAC), and the striatal tissue was procured to quantify trace elements, dopamine, and DOPAC. The collection procedure adhered to sterile conditions and employed plastic utensils to avert potential metal contamination from dissection tools. Afterward, the tissue was delicately dried on the filter paper, weighed, and preserved at −20°C until subsequent analysis. Both blood plasma and striatal tissue were stored in a −80°C freezer until biochemical assays were conducted.

2.4.5.1. Measurement of dopamine and DOPAC levels

In this study, we employed an HPLC system (Agilent Technologies HP 1100 series) equipped with electrochemical detection (Agilent Hewlett Packard 1049A) set to a potential of 750 mV. The analysis focused on dopamine and its metabolites, specifically 3,4-hydroxyphenylacetic acid (DOPAC). To prepare the samples, the striatal homogenate was thawed and then subjected to centrifugation at 4°C for 2 min at 12,000 g. For each sample, 10 μL of the resulting supernatant was injected into an Agilent LiChrospher 100 cartridge column (RP-18, 5 μm, 3 × 125 mm) maintained at 4°C.

The mobile phase composition consisted of 0.1 M Na2HPO4 (pH 3.3), 0.15 mM EDTA, and 25% methanol. A flow rate of 0.8 ml/min was used during the chromatographic separation. To identify the analytes (dopamine and DOPAC), their retention times were compared to those of corresponding standards. The concentration of each analyte was determined by calculating the area under the curve using the equation y = mx + c and expressed in ng/mg protein (Abboussi et al., 2020).

2.4.5.2. Trace element analysis

The analysis of trace elements was conducted using inductively coupled plasma optical emission spectrometry (ICP-OES) based on a modified method described by Golden et al. (2001). In brief, the striatal tissue was sonicated in 2N hydrochloric acid (HCl) (0.5 ml) for homogenization. Subsequently, each sample was incubated with 70% perchloric acid (0.1 ml) at 50°C in a water bath for 24–36 h. After the incubation period, the samples were centrifuged at 3,500 rpm for 1 h and filtered through a 0.45 μm pore size filter using a filter syringe. The analysis of samples and standards was performed using the Perkin Elmer Optima 5,300 DV Optimal Emission Spectrometer (Waltham MA, USA).

2.4.5.3. Total antioxidant capacity

The total antioxidant capacity (TAC) is a measure of the collective antioxidant activity displayed by biomolecules in a sample. To assess TAC, whole blood was subjected to centrifugation at 3,500 rpm for 10 min, resulting in the collection of plasma. The plasma was then analyzed for TAC using the OxiSelect™ Total Antioxidant Capacity Assay kit (Cell Biolabs Inc., UK) following the instructions provided by the manufacturer.

2.5. Statistical analysis

Statistical analysis was performed using Graph-Pad Prism software 8.0. Statistical significance was set at a p-value of <0.05, and data are expressed as mean ± SEM. The normality of data was assessed by the Shapiro test. Differences in mean values were analyzed with a one-way or two-way ANOVA test followed by a Bonferroni post-hoc test for all experimental data. All figures were prepared using Graph-Pad Prism version 8.0.

3. Results

3.1. Chemical composition of AU extract

Figure 2 and Table 1 represent the chromatogram and the phytoconstituents of the aqueous extract from A. unedo fruits, respectively. Phytochemical analysis of the aqueous extract from A. unedo fruits, via LC-MS/MS, revealed 35 compounds, mainly phenolic and organic acids, and flavonoids, and their chemical structures are illustrated in Figure 3. Quinic acid, an example of organic acid, along with its malate, gallate, and digallate derivatives were tentatively identified based on their molecular weights (191, 307, 343, and 495, respectively) and corresponding fragment 191 (Table 1). Several gallic acid derivatives, examples of phenolic acid, were also present. These include galloyl glucose, gallic acid- malate, -shikimate, -glucuronide, and -rhamnosyl gallate along with two digalloyl glucose isomers (Table 1). Noteworthy, galloyl hexahydroxydiphenoyl (HHDP)-glucoside, an example of ellagitannins, was also detected in the extract. Mono- and di-glycosides of apigenin, kaempferol, quercetin, and isorhamnetin, examples of flavonoid glycosides, were found in the extract as well.

FIGURE 2
www.frontiersin.org

Figure 2. LC/MS/MS chromatogram of the aqueous extract from A. unedo fruit.

TABLE 1
www.frontiersin.org

Table 1. Annotated metabolites from the aqueous extract from A. unedo fruits.

FIGURE 3
www.frontiersin.org

Figure 3. Chemical structures of the bioactive compounds found in the aqueous extract from A. unedo fruit.

3.2. In vitro antioxidant capacity of AU extract

In the current study, the antioxidant activity of AU extract was estimated through DPPH and ABTS assay. AU extract and vitamin C displayed promising antioxidant activities in a dose-dependent manner. AU extract displayed stronger in vitro radical scavenging activity against DPPH radicals than ABTS radicals (Table 2).

TABLE 2
www.frontiersin.org

Table 2. Antioxidant potential of the AU extract compared to the positive control vitamin C.

3.3. Effect of AU extract on PQ-decreased dopaminergic cells viability

As depicted in Figure 4A, MTT results showed that PQ-affected dopaminergic cells viability where the stimulation with PQ concentrations of 250 and 500 μM significantly decreased cell viability compared to the control group (p < 0.0001), while the treatment with AU extract on different concentrations seems to have no significant effect on cells viability (p > 0.05). The AU extract at 5,000 μM significantly enhanced cell viability affected by PQ, while the AU extract at 1,000 μM seems to have no significant effect against PQ-induced cytotoxicity (p > 0.9999).

FIGURE 4
www.frontiersin.org

Figure 4. (A) Results of MTT assay on dopaminergic cell viability after 4 h of exposure to different concentrations of PQ (10–500 μM), AU (10–10,000 μg/mL) (upper graph), and the combination of PQ (250 μM) and AU at 1,000 μg/ml (AU1) and 5,000 μg/ml (AU5) (lower graph). Data were normalized as a percentage of control (complete culture media). Results are expressed as mean ± SEM from eight biological replicates (upper graph). Ordinary one-way ANOVA multiple comparisons test significant differences, ***p < 0.001 compared with the control group (lower graph). Bonferroni's multiple comparisons test revealed significant differences; *p < 0.05 and ***p < 0.001 compared to all saline groups, ##p < 0.01 compared to the PQ group. (B) AU extract (5,000 μg/ml) and PQ (250 μM) effects on dopaminergic cells mitochondrial respiratory parameters. Data are presented as the mean of five independent experiments, as means ± SEM, significance was assessed by the Bonferroni post-hoc test; *p < 0.05 vs. Vehicle: Vehicle, #p < 0.05 vs. Vehicle: AU, $p < 0.05 vs. PQ: Vehicle.

3.4. AU extract effects on PQ-induced mitochondrial bioenergetics impairment

XFe24 Seahorse analyzer was used to determine whether PQ-induced bioenergetic mitochondrial profile impairment in N27 dopaminergic neural cells is alleviated by the AU extract. Oxidative respiration expressed as oxygen consumption rate (OCR) (Figure 4B) was measured for neural cells after 4 h of PQ, AU, or both exposures. Two-way ANOVA analysis of Mito stress test data revealed significant interactions between PQ and AU treatments on maximal respiration [F(1, 16) = 8.67, p = 0.0095], non-mitochondrial respiration [F(1, 16) = 103.3, p < 0.0001], proton leak [F(1, 16) = 44.67, p < 0.0001], spare respiratory capacity [F(1, 16) = 27.97, p < 0.0001], ATP production [F(1, 16) = 4.678, p = 0.0460], and ATP coupling efficiency [F(1, 16) = 39.29, p < 0.0001]. While no significant effect was shown on basal respiration rate [F(1, 16) = 1.86, p = 0.1912]. The Bonferroni post-hoc test showed that PQ significantly increased the non-mitochondrial respiration and the proton leak compared to the control (Vehicle: Vehicle, p < 0.0001 and p < 0.0001, respectively), AU-treated cells (Vehicle: AU, p < 0.0001 and p < 0.0001, respectively), and AU-treated cell after PQ exposure (PQ: AU, p < 0.0001 and p < 0.0001). It significantly decreased the maximal respiration rate compared to the control group (p = 0.0020). In addition, PQ significantly decreased the spare respiratory capacity of neuronal cells, their ATP production, and their coupling efficiency compared to all vehicle groups, and the AU extract inhibits this side effect by increasing significantly rate of these parameters (p = 0.0016, p = 0.0056, and p < 0.0001, respectively; PQ: vehicle vs. PQ: AU).

3.5. Behavioral analysis

3.5.1. Effect of PQ and the AU extract on the forelimb stepping test

To evaluate the AU extract effect on PQ-induced akinesia on rat progeniture, the step length was estimated by the forelimb stepping test. Two-way ANOVA demonstrated a significant interaction between the group treated with the AU extract after the pretreatment with PQ and the group treated with PQ alone [F(1, 28) = 7.112, p = 0.0126]. As depicted in Figure 5A, rats treated with the AU extract alone showed no significant effect on the step length of their progeniture compared to the vehicle group (p > 0.9999). Posttreatment of rats with the AU extract at a dose of 1 g/kg after PQ exposure significantly reversed akinesia (p = 0.0251) observed in rat progeny by improving their step length.

FIGURE 5
www.frontiersin.org

Figure 5. (A) Effects of the AU extract on PQ-reduced step length in the forelimb stepping test. (B) Effects of the AU extract on PQ induced a deficit in the usage of the contralateral forelimbs by rats' progeny in the cylinder test for asymmetry. (C) Effects of prenatal PQ exposure and treatment with AU on dopamine (DA), DOPAC levels in the striatum of rats' progeny, and DA turnover expressed as DOPAC/DA ratio. Each value is expressed as mean ± SEM (n = 8). Significance was assessed by the Bonferroni post-hoc test when there is significant interaction between the AU extract and PQ treatment; *p < 0.05 vs. Vehicle: Vehicle, #p < 0.05 vs. Vehicle: AU, $p < 0.05 vs. PQ: Vehicle.

3.5.2. AU treatment inhibits PQ-induced deficit in contralateral forelimb use

To test the effect of AU treatment on PQ prenatally exposure induced a deficit in motor coordination, and contralateral forelimb use was evaluated by the cylinder test for asymmetry (Figure 5B). Two-way ANOVA analysis revealed a significant interaction between PQ exposure and AU treatment [F(1, 28) = 8.944, p = 0.0057]. As depicted in Figure 5B, Bonferroni's multiple comparison test revealed that prenatal exposure to PQ induced a significant deficit in the usage of the contralateral forelimb by rat progeniture (p < 0.0001). This deficit was significantly decreased by AU treatment (p < 0.0001).

3.5.3. AU treatment reduces PQ-induced dopamine depletion in the striatum

The DA and DOPAC levels measured in the striatum indicated that PQ decreased dopamine levels [F(1, 28) = 125.4, p < 0.0001] and its metabolite DOPAC [F(1, 28) = 17.63, p = 0.0002] as well as DA turnover [F(1, 28) = 4.364, p = 0.0459] (Figure 5C). However, AU increased significantly both DA [F(1, 28) = 8.188, p = 0.0079] and DOPAC [F(1, 28) = 7.799, p = 0.0093] levels as revealed by ANOVA two-way analysis. No interaction between PQ and AU treatments was revealed when evaluating the DA level [F(1, 28) = 0.7071, p = 0.4075], neither the DOPAC level [F(1, 28) = 0.8213, p = 0.3725] nor DA turnover [F(1, 28) = 2.365, p = 0.1353].

3.5.4. PQ and AU effects on striatum trace elements level

The effect of the prenatal exposure of PQ on iron, copper, zinc, and manganese levels at the striatal tissue of PND 75 is shown in Figure 6A. Two-way ANOVA revealed significant interactions between prenatal PQ exposure and AU treatment [F(1, 28) = 10.66, p = 0.0029] on iron levels, where PQ significantly increases its level in the striatal tissue of rats at the PND75 compared to the control group (Vehicle: Vehicle; p < 0.0001) and the group prenatally exposed to the AU extract (Vehicle: AU; p < 0.0001). The Bonferroni post-hoc test also showed that this effect is significantly alleviated with co-treatment with the AU extract alongside PQ exposure (PQ: AU; p = 0.0002). However, no significant interactions were shown on striatal levels of zinc [F(1, 28) = 1.330; p = 0.2585], copper [F(1, 28) = 3.499; p = 0.0719], and manganese [F(1, 28) = 0.6196; p = 0.4378].

FIGURE 6
www.frontiersin.org

Figure 6. (A) Trace element levels at the striatal tissue of PND 75 prenatally exposed to the PQ (20 mg/kg) and the effect of the co-treatment with the AU extract (1 g/kg). (B) PQ prenatal exposure decreased TAC in the blood plasma of rats at PND 75 and treatment with AU extract alleviated this effect. Data are expressed as mean ± SEM (n = 8). Significance was assessed by the Bonferroni post-hoc test when there is significant interaction between AU extract and PQ treatments; *p < 0.05 vs. Vehicle: Vehicle, #p < 0.05 vs. Vehicle: AU, $p < 0.05 vs. PQ: Vehicle.

3.5.5. AU treatment hides PQ prenatal exposure-induced TAC decrease

As depicted in Figure 6B, a significant effect of AU and PQ on TAC in the blood plasma of rats at PND 75 is shown. Two-way ANOVA revealed significant interactions between AU and PQ treatments [F(1, 28) = 6.265; p = 0.0184], where PQ prenatal exposure reduced significantly the TAC in the blood plasma compared to the control group (Vehicle: Vehicle; p < 0.0001), while the co-treatment with AU extract significantly hides this PQ effect by increasing TAC in the blood plasma (PQ: AU, p < 0.0001). In addition, AU prenatal treatment significantly improved the TAC in the plasma blood of rats at PND75 compared to the control group (Vehicle: Vehicle, p = 0.0264), which highlights the antioxidant effect of this extract related to its bioactive compounds.

4. Discussion

PQ, a well-known herbicide for its irreversibly detrimental effects on the brain in animal models, causes neuronal cell death in the substantia nigra (Liou et al., 1996; Manning-Bog et al., 2002; Somayajulu-Nitu et al., 2009), behavioral abnormalities (Fernagut et al., 2007), oxidative stress (Chen et al., 2010; Ishola et al., 2019), and mitochondrial respiration impairments (Czerniczyniec et al., 2015; Wang et al., 2018; Ishola et al., 2019). Recently, it was demonstrated that prenatal PQ exposure induces neurotoxicity in mouse offspring, leading to several neurochemical alterations and altered brain development (Ait-Bali et al., 2016; Hamdaoui et al., 2022). In this regard, treatments for PQ poisoning may include the modulation of the levels of glutathione-utilizing antioxidant agents, selenium compounds, as well as metal chelators utilization (Blanco-Ayala et al., 2014). However, some of these are not long-lasting and may show side effects.

In this respect, numerous studies highlighted that phytoconstituents, including polyphenols, may exert antioxidant activities. As reported in Table 1, in our study, we used an aqueous AU extract that primarily comprises phenolic compounds alongside flavonoid glycosides, which are widely known for their antioxidant activities (Grabska-Kobylecka et al., 2020). Based on these findings, we first assessed the neuroprotective effects of AU extract against PQ-induced cytotoxicity and mitochondrial impairments in the N27 dopaminergic cell line. Then, we investigated the effect of AU extract on motor function, dopamine, and trace element levels in the striatum as well as its effect on plasmatic total antioxidant capacity (TAC) in PQ-prenatally exposed Wistar rats.

For that, the rats were treated with the AU extract 2 h after the oral administration of PQ to minimize any potential interactions between the two treatments. This decision was based on a previous study investigating the toxicokinetics and bioavailability of PQ. The study reported a terminal half-life of [14C] PQ of 68.0 ± 23.0 min following intragastric administration, indicating a rapid clearance from the bloodstream (Chui et al., 1988). By allowing a 2-h interval between the two treatments, we aimed to ensure that the effects of PQ administration were adequately established before introducing the AU extract. This approach was employed to enable a focused evaluation of the neuroprotective effects of the AU extract without any confounding influences from immediate interactions between the two compounds.

Our results demonstrated that PQ treatment at 250 and 500 μM significantly decreased cell viability, confirming the findings of earlier studies on PQ neurotoxicity (Chen et al., 2008; Ortiz-Ortiz et al., 2009; Han et al., 2019). These studies have shown that PQ-induced dopaminergic cell death might be mediated by its effect on dopaminergic neurons (Choi et al., 2008; See et al., 2022). They demonstrated that PQ is recycled via mitochondrial complex I, leading to its activation and ROS production, which causes oxidative stress and apoptosis. Treatment of N27 cells with the AU extract at 5,000 μg/mL significantly protected them against PQ toxicity. This effect may be principally mediated by the presence of several antioxidant compounds, as reported before, particularly gallic acid and its derivatives, quercetin, apigenin, kaempferol, and rutin (Figure 7). Gallic acid and its derivatives have a potential protective effect against neuronal damage by inhibiting mitochondrial apoptotic signaling molecules and scavenging ROS, including hydroxyl radicals, superoxide anions, and hydrogen peroxide (Shabani et al., 2020). Furthermore, there is substantial scientific evidence documenting the ability of flavonoids, specifically quercetin and apigenin, to mitigate the loss of neuronal cells by reducing oxidative stress. Quercetin achieves this effect by attenuating the activities of xanthine oxidase and nitric oxide (NO) synthase and upregulating the activity of mitochondrial complex I (Karuppagounder et al., 2013; Islam et al., 2021). On the other hand, apigenin exerts its neuroprotective effects by inhibiting dopaminergic neuronal cell death through anti-inflammatory mechanisms mediated by the upregulation of peroxisome proliferator-activated receptor-gamma (PPARγ) and the suppression of oxidative stress induced by rotenone (Li et al., 2016; Anusha et al., 2017). Additionally, rutin and kaempferol have been reported to protect dopaminergic neurons against 6-OHDA and rotenone-induced neurotoxicity in SH-SY5Y cells and primary neurons, respectively. This neuroprotection is highlighted by increasing superoxide dismutase and glutathione activity and reducing lipid peroxidation levels (Filomeni et al., 2012; Moshahid Khan et al., 2012).

FIGURE 7
www.frontiersin.org

Figure 7. Illustration of the mechanism behind the antioxidant capabilities of AU extract protecting neurons from PQ-induced cell death (Created with BioRender.com).

Our findings also demonstrated that PQ exposure at a low concentration (250 μM) led to impairments of mitochondrial respiration in N27 dopamine cells. This is consistent with other studies, collectively highlighting the detrimental effects of PQ on mitochondrial respiration in neuronal cells, mainly affecting complex I and IV activity, leading to impaired electron transport chain function and reduced ATP production (Czerniczyniec et al., 2011; Wang et al., 2018; de Oliveira Souza et al., 2019). In our study, the AU extract significantly mitigated the PQ-induced abnormal mitochondrial functioning of N27 dopamine cells. It was observed to increase oxygen consumption rate (OCR), decrease proton leak, and enhance the maximal respiratory capacity of dopaminergic neurons and their coupling efficiency. These effects could be mediated by its antioxidant properties, which can help counteract PQ-induced oxidative stress by scavenging reactive oxygen species (ROS), protecting mitochondrial components, and maintaining their functional integrity, thereby supporting normal mitochondrial respiration (Dabaghi-Barbosa et al., 2005; Wolf et al., 2010; Xiao et al., 2022). Additionally, it has been demonstrated that phenolic acids present in the AU extract activate Nrf2 (nuclear factor erythroid 2-related factor 2) (Tambe et al., 2023), which is associated with the activation of mitochondrial biogenesis and enhancement of mitochondrial activity by upregulating the expression of key genes involved in mitochondrial DNA replication and maintaining the integrity of the mitochondrial membrane potential, which is essential for mitochondrial function (Tufekci et al., 2011; Ryoo and Kwak, 2018).

Behavioral assessments revealed that prenatal exposure to PQ resulted in motor deficits resembling akinesia in rat offspring, consistent with previous studies indicating PQ-induced motor incoordination and reduced spontaneous motor behavior due to degeneration of the nigrostriatal dopaminergic system (Li et al., 2005; Colle et al., 2020). Interestingly, the administration of AU significantly mitigated these motor deficits caused by PQ, suggesting a positive effect on motor function. This beneficial effect could potentially be attributed to the presence of AU polyphenols, particularly gallic acid, which has been reported as an effective compound against PQ/iron co-treatment-induced impairment of normal movement functionality in Drosophila melanogaster (Jimenez-Del-Rio et al., 2010). Furthermore, the loss of dopaminergic neurons is associated with a decline in dopamine (DA) levels and its metabolite, DOPAC, leading to a reduction in the DOPAC/DA ratio (DA turnover). Our results demonstrated that AU alleviated PQ-induced dopamine depletion and decreased DA turnover in the striatal tissue of rat progeny. These effects could be mediated by the bioactive compounds of AU, particularly kaempferol, quercetin, and apigenin. Kaempferol, for instance, has been shown to prevent MPTP-induced Parkinson's disease in C57BL/6 mice by inhibiting dopaminergic neuron loss, increasing dopamine and DOPAC levels, and enhancing DA turnover. These effects were associated with the increased activity of antioxidant enzymes such as superoxide dismutase (SOD) and glutathione peroxidase (GPx), as well as a reduction in the levels of malondialdehyde (MDA), a marker of lipid peroxidation and oxidative damage. Additionally, kaempferol improved performance in spontaneous motor activity tests, indicating its positive impact on motor behavior (Shahpiri et al., 2016). Similarly, recent studies have demonstrated the neuroprotective effects of quercetin in attenuating rotenone-induced toxicity by reducing redox stress in the striatum, optimizing dopamine metabolism, and improving neuronal density depletion (Josiah et al., 2022). In the same Parkinson's disease model, apigenin has been shown to modulate dopaminergic neurotransmission by downregulating α-synuclein expression and enhancing dopamine biosynthesis through the upregulation of dopamine D2 receptor protein expression and tyrosine hydroxylase (Anusha et al., 2017).

Furthermore, our findings revealed that prenatal exposure to PQ disrupted iron homeostasis, leading to increased striatal iron levels. PQ has been shown to interfere with iron metabolism and its release from Fe-S cluster proteins in the mitochondrial respiratory chain, resulting in iron accumulation (Dixon and Stockwell, 2014; Onukwufor et al., 2022). This iron accumulation contributes to oxidative stress and neurodegeneration through the generation of reactive oxygen species (ROS) via the Fenton reaction. Interestingly, treatment with the AU extract effectively attenuated the PQ-induced increase in striatal iron levels, suggesting its potential as an iron-chelating agent. Previous studies have reported the iron-chelating capacity of flavonoids and other compounds present in the AU extract, highlighting their ability to sequester excessive iron and prevent iron-induced oxidative damage (Porfírio et al., 2014; Kejík et al., 2021). Importantly, PQ exposure did not significantly alter the levels of other metal ions, such as copper, zinc, and manganese, in the striatal tissue. This selectivity of PQ in inducing alterations specifically in iron homeostasis without affecting other metal ions is noteworthy. Similarly, treatment with the AU extract did not significantly affect the levels of these metals, indicating its specific action in addressing iron dysregulation associated with prenatal PQ exposure.

Additionally, our results demonstrated that prenatal PQ exposure resulted in a reduction in total antioxidant capacity (TAC) in the blood plasma of the rat offspring, indicating a diminished ability to neutralize ROS and protect against oxidative damage. This effect can be attributed to PQ-induced ROS generation, as previously reported, which depletes endogenous antioxidants in the body, including enzymes such as superoxide dismutase (SOD), catalase (CAT), and glutathione (GSH) peroxidase (Sengupta et al., 2017; Hasanuzzaman et al., 2018). These enzymes play a crucial role in scavenging and neutralizing ROS; however, PQ overwhelms their capacity, leading to decreased antioxidant levels. Notably, treatment with the AU extract effectively mitigated this effect by significantly improving TAC in the blood plasma of PQ-exposed rat offspring. This can be attributed to the bioactive compounds present in AU, particularly polyphenols and flavonoids, which have been shown to upregulate the activity and expression of SOD, CAT, and GSH while downregulating the expression of malondialdehyde (MDA), a marker of oxidative damage (Alvarez-Suarez et al., 2011; Gao et al., 2022). Consequently, the AU extract helps maintain a balance between ROS production and antioxidant defense in the body.

In summary, our results suggested that the AU extract inhibited prenatal PQ-induced neurotoxicity by preserving dopaminergic cell viability, improving mitochondrial function, ameliorating motor deficits, and restoring iron homeostasis. The polyphenolic compounds present in the AU extract, such as gallic acid, quercetin, apigenin, kaempferol, and rutin, likely contribute to these neuroprotective effects through their antioxidant, anti-apoptotic, and iron-chelating properties. Further investigations are warranted to elucidate the underlying mechanisms and assess the translational potential of AU extract as a therapeutic intervention for PQ poisoning and related neurodegenerative disorders.

Data availability statement

The original contributions presented in the study are included in the article/Supplementary material, further inquiries can be directed to the corresponding authors.

Ethics statement

The animal study was approved by University of Mohammed V Animal Ethics Research Committee, under the Ethical Approval Number MAM5 70-8647. The study was conducted in accordance with the local legislation and institutional requirements.

Author contributions

OA and ZA developed the overall study objectives. OA, MS, KT, and MA designed the methodology. ZA, HI, SE, MS, and OA performed most of the experimental analysis and wrote the first draft of the manuscript. FA pre-processed experimental data and assisted in some experiments and manuscript writing. MS and OA assisted in collating the data and interpreting the results. WM, KT, MA, and OA reviewed and revised the manuscript. All authors contributed to the article and approved the submitted version.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fnins.2023.1244603/full#supplementary-material

References

Abboussi, O., Andaloussi, Z. I. L., Chris, A. D., and Taghzouti, K. (2020). Chronic exposure to WIN55, 212-2 during adolescence alters prefrontal dopamine turnover and induces sensorimotor deficits in adult rats. Neurotox. Res. 38, 682–690. doi: 10.1007/s12640-020-00266-1

PubMed Abstract | CrossRef Full Text | Google Scholar

Ait Lhaj, Z., Bchitou, R., Gaboun, F., Abdelwahd, R., Benabdelouahab, T., Kabbour, M. R., et al. (2021a). Moroccan strawberry tree (Arbutus unedo L.) fruits: nutritional value and mineral composition. Foods 10, 2263. doi: 10.3390/foods10102263

PubMed Abstract | CrossRef Full Text | Google Scholar

Ait Lhaj, Z., Zouahri, A., Abboussi, O., Ibork, H., Diria, G., Bakhy, K., et al. (2021b). Influences of the soil physico-chemical characteristics on the mineral composition of the moroccan strawberry tree (Arbutus unedo L.). J. Exp. Biol. Agric. Sci. 9, 294–304. doi: 10.18006/2021.9(3).294.304

CrossRef Full Text | Google Scholar

Ait-Bali, Y., Ba-M'hamed, S., and Bennis, M. (2016). Prenatal Paraquat exposure induces neurobehavioral and cognitive changes in mice offspring. Environ. Toxicol. Pharmacol. 48, 53–62. doi: 10.1016/j.etap.2016.10.008

PubMed Abstract | CrossRef Full Text | Google Scholar

Alrashidi, H. (2022). Biochemical Characterisation of Parkinson's Disease Models. London: UCL (University College London).

Google Scholar

Alvarez-Suarez, J. M., Dekanski, D., Ristić, S., Radonjić, N. V., Petronijević, N. D., Giampieri, F., et al. (2011). Strawberry polyphenols attenuate ethanol-induced gastric lesions in rats by activation of antioxidant enzymes and attenuation of MDA increase. PLoS ONE 6, e25878. doi: 10.1371/journal.pone.0025878

PubMed Abstract | CrossRef Full Text | Google Scholar

Anusha, C., Sumathi, T., and Joseph, L. D. (2017). Protective role of apigenin on rotenone induced rat model of Parkinson's disease: suppression of neuroinflammation and oxidative stress mediated apoptosis. Chemico-biol. Interact. 269, 67–79. doi: 10.1016/j.cbi.2017.03.016

PubMed Abstract | CrossRef Full Text | Google Scholar

Arnao, M. B., Cano, A., and Acosta, M. (2001). The hydrophilic and lipophilic contribution to total antioxidant activity. Food Chem. 73, 239–244. doi: 10.1016/S0308-8146(00)00324-1

CrossRef Full Text | Google Scholar

Aruoma, O. I., Bahorun, T., and Jen, L.-S. (2003). Neuroprotection by bioactive components in medicinal and food plant extracts. Mutat. Res. Rev. Mutat. Res. 544, 203–215. doi: 10.1016/j.mrrev.2003.06.017

PubMed Abstract | CrossRef Full Text | Google Scholar

Beppe, G. J., Dongmo, A. B., Foyet, H. S., Tsabang, N., Olteanu, Z., Cioanca, O., et al. (2014). Memory-enhancing activities of the aqueous extract of Albizia adianthifolia leaves in the 6-hydroxydopamine-lesion rodent model of Parkinson's disease. BMC Complem. Altern. Med. 14, 142. doi: 10.1186/1472-6882-14-142

PubMed Abstract | CrossRef Full Text | Google Scholar

Berry, C., La Vecchia, C., and Nicotera, P. (2010). Paraquat and Parkinson's disease. Cell Death Different. 17, 1115–1125. doi: 10.1038/cdd.2009.217

CrossRef Full Text | Google Scholar

Bjorklund, G., Stejskal, V., Urbina, M. A., Dadar, M., Chirumbolo, S., and Mutter, J. (2018). Metals and Parkinson's disease: mechanisms and biochemical processes. Curr. Med. Chem. 25, 2198–2214. doi: 10.2174/0929867325666171129124616

PubMed Abstract | CrossRef Full Text | Google Scholar

Blanco-Ayala, T., Andérica-Romero, A., and Pedraza-Chaverri, J. (2014). New insights into antioxidant strategies against paraquat toxicity. Free Rad. Res. 48, 623–640. doi: 10.3109/10715762.2014.899694

PubMed Abstract | CrossRef Full Text | Google Scholar

Bonaccorso Marinelli, M., Ledesma, M., Nieto Grimalt, F., and Cabrera, R. (2017). “Video tracking analysis system for Forelimb Akinesia test in the rat Parkinson model,” in VII Latin American Congress on Biomedical Engineering CLAIB 2016. Bucaramanga, Santander, Colombia, October 26th-28th 2016. Springer, 745–748.

Google Scholar

Carral, X. S. (2015). Estructura genética y variación geográfica en caracteres ecofisiológicos de Arbutus unedo L. Ecosistemas 24, 93–97. doi: 10.7818/ECOS.2013.24-3.12

CrossRef Full Text | Google Scholar

Chakrabarti, N. (2015). Trends in research on paraquat-induced parkinsonism. Indian J. Physiol. Allied Sci. 69, 103–116. doi: 10.55184/ijpas.v69i04.17

CrossRef Full Text | Google Scholar

Chaouhan, H. S., Li, X., Sun, K.-T., Wang, I.-K., Yu, T.-M., Yu, S.-H., et al. (2022). Calycosin alleviates paraquat-induced neurodegeneration by improving mitochondrial functions and regulating autophagy in a drosophila model of Parkinson's disease. Antioxidants 11, 222. doi: 10.3390/antiox11020222

PubMed Abstract | CrossRef Full Text | Google Scholar

Chen, P., Li, A., Zhang, M., He, M., Chen, Z., Wu, X., et al. (2008). Protective effects of a new metalloporphyrin on paraquat-induced oxidative stress and apoptosis in N27 cells. Acta biochimica et biophysica Sinica 40, 125–132. doi: 10.1111/j.1745-7270.2008.00386.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Chen, Q., Niu, Y., Zhang, R., Guo, H., Gao, Y., Li, Y., et al. (2010). The toxic influence of paraquat on hippocampus of mice: involvement of oxidative stress. Neurotoxicology 31, 310–316. doi: 10.1016/j.neuro.2010.02.006

PubMed Abstract | CrossRef Full Text | Google Scholar

Choi, W.-S., Kruse, S. E., Palmiter, R. D., and Xia, Z. (2008). Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP+, or paraquat. Proc. Natl. Acad. Sci. 105, 15136–15141. doi: 10.1073/pnas.0807581105

PubMed Abstract | CrossRef Full Text | Google Scholar

Choukairi, Z., Lamri, L., El Alaoui, C., Hazzaz, T., and Fechtali, T. (2015). Parkinson disease research: distinct animal models and therapeutic approach. Int. J. Sci. Res. 4.

Google Scholar

Chui, Y. C., Poon, G., and Law, F. (1988). Toxicokinetics and bioavailability of paraquat in rats following different routes of administration. Toxicol. Industr. Health 4, 203–219.

PubMed Abstract | Google Scholar

Colle, D., and Farina, M. (2021). “Oxidative stress in paraquat-induced damage to nervous tissues,” in Toxicology. Academic Press, 69–78. doi: 10.1016/B978-0-12-819092-0.00008-X

CrossRef Full Text | Google Scholar

Colle, D., Santos, D. B., Naime, A. A., Gonçalves, C. L., Ghizoni, H., Hort, M. A., et al. (2020). Early postnatal exposure to paraquat and maneb in mice increases nigrostriatal dopaminergic susceptibility to a Re-challenge with the same pesticides at adulthood: implications for Parkinson's disease. Neurotox. Res. 37, 210–226. doi: 10.1007/s12640-019-00097-9

PubMed Abstract | CrossRef Full Text | Google Scholar

Czerniczyniec, A., Karadayian, A. G., Bustamante, J., Cutrera, R. A., and Lores-Arnaiz, S. (2011). Paraquat induces behavioral changes and cortical and striatal mitochondrial dysfunction. Neurotox. Res. 51, 1428–1436. doi: 10.1016/j.freeradbiomed.2011.06.034

PubMed Abstract | CrossRef Full Text | Google Scholar

Czerniczyniec, A., Lanza, E., Karadayian, A. G., Bustamante, J., and Lores-Arnaiz, S. J. (2015). Impairment of striatal mitochondrial function by acute paraquat poisoning. J. Bioenerg. Biomemb. 47, 395–408. doi: 10.1007/s10863-015-9624-x

PubMed Abstract | CrossRef Full Text | Google Scholar

Dabaghi-Barbosa, P., Mariante Rocha, A., Franco Da Cruz Lima, A., and Heleno De Oliveira, B. (2005). Hispidulin: antioxidant properties and effect on mitochondrial energy metabolism. Free Rad. Res. 39, 1305–1315. doi: 10.1080/13561820500177659

PubMed Abstract | CrossRef Full Text | Google Scholar

de Oliveira Souza, A., Couto-lima, C. A., Catalão, C. H. R., Santos-Júnior, N. N., Dos Santos, J. F., Da Rocha, M. J. A., et al. (2019). Neuroprotective action of Eicosapentaenoic (EPA) and Docosahexaenoic (DHA) acids on Paraquat intoxication in Drosophila melanogaster. Neurotoxicology 70, 154–160. doi: 10.1016/j.neuro.2018.11.013

PubMed Abstract | CrossRef Full Text | Google Scholar

Dixon, S. J., and Stockwell, B. R. (2014). The role of iron and reactive oxygen species in cell death. Nat. Chem. Biol. 10, 9–17. doi: 10.1038/nchembio.1416

PubMed Abstract | CrossRef Full Text | Google Scholar

Fernagut, P.-O., Hutson, C., Fleming, S., Tetreaut, N., Salcedo, J., Masliah, E., et al. (2007). Behavioral and histopathological consequences of paraquat intoxication in mice: effects of α-synuclein over-expression. Synapse 61, 991–1001. doi: 10.1002/syn.20456

PubMed Abstract | CrossRef Full Text | Google Scholar

Fernandes, L., Santos, A., Sampaio, T., Sborgi, S., Prediger, R., Ferro, M., et al. (2021). Exposure to paraquat associated with periodontal disease causes motor damage and neurochemical changes in rats. Hum. Exp. Toxicol. 40, 81–89. doi: 10.1177/0960327120938851

PubMed Abstract | CrossRef Full Text | Google Scholar

Filomeni, G., Graziani, I., De Zio, D., Dini, L., Centonze, D., Rotilio, G., et al. (2012). Neuroprotection of kaempferol by autophagy in models of rotenone-mediated acute toxicity: possible implications for Parkinson's disease. Neurobiol. Aging 33, 767–785. doi: 10.1016/j.neurobiolaging.2010.05.021

PubMed Abstract | CrossRef Full Text | Google Scholar

Fortalezas, S., Tavares, L., Pimpão, R., Tyagi, M., Pontes, V., Alves, P. M., et al. (2010). Antioxidant properties and neuroprotective capacity of strawberry tree fruit (Arbutus unedo). Nutrients 2, 214–229. doi: 10.3390/nu2020214

PubMed Abstract | CrossRef Full Text | Google Scholar

Fukushima, T., Tan, X., Luo, Y., and Kanda, H. (2011). Serum vitamins and heavy metals in blood and urine, and the correlations among them in Parkinson's disease patients in China. Neuroepidemiology 36, 240–244. doi: 10.1159/000328253

PubMed Abstract | CrossRef Full Text | Google Scholar

Gao, S.-H., Zhao, T.-R., Liu, Y.-P., Wang, Y.-F., Cheng, G.-G., and Cao, J.-X. (2022). Phenolic constituents, antioxidant activity and neuroprotective effects of ethanol extracts of fruits, leaves and flower buds from Vaccinium dunalianum Wight. Food Chem. 374, 131752. doi: 10.1016/j.foodchem.2021.131752

PubMed Abstract | CrossRef Full Text | Google Scholar

Gerfen, C. R. (2000). Molecular effects of dopamine on striatal-projection pathways. Trends Neurosci. 23, S64–S70. doi: 10.1016/S1471-1931(00)00019-7

PubMed Abstract | CrossRef Full Text | Google Scholar

Ghareeb, M. A., Mohamed, T., Saad, A. M., Refahy, L. A.-G., Sobeh, M., and Wink, M. J. (2018). HPLC-DAD-ESI-MS/MS analysis of fruits from Firmiana simplex (L.) and evaluation of their antioxidant and antigenotoxic properties. J. Pharm. Pharmacol. 70, 133–142. doi: 10.1111/jphp.12843

PubMed Abstract | CrossRef Full Text | Google Scholar

Golden, J., Levy, T. E., and Hauptmann, A. J. (2001). Recent discoveries concerning Chalcolithic metallurgy at Shiqmim, Israel. J. Archaeol. Sci. 28, 951–963. doi: 10.1006/jasc.2000.0626

CrossRef Full Text | Google Scholar

Grabska-Kobylecka, I., Kaczmarek-Bak, J., Figlus, M., Prymont-przyminska, A., Zwolinska, A., Sarniak, A., et al. (2020). The presence of caffeic acid in cerebrospinal fluid: evidence that dietary polyphenols can cross the blood-brain barrier in humans. Nutrients 12, 1531. doi: 10.3390/nu12051531

PubMed Abstract | CrossRef Full Text | Google Scholar

Hamdaoui, Q., Zekri, Y., Richard, S., Aubert, D., Guyot, R., Markossian, S., et al. (2022). Prenatal exposure to paraquat and nanoscaled TiO2 aerosols alters the gene expression of the developing brain. Chemosphere 287, 132253. doi: 10.1016/j.chemosphere.2021.132253

PubMed Abstract | CrossRef Full Text | Google Scholar

Han, J., Kim, S. J., Ryu, M. J., Jang, Y., Lee, M. J., Ju, X., et al. (2019). Chloramphenicol mitigates oxidative stress by inhibiting translation of mitochondrial complex I in dopaminergic neurons of toxin-induced Parkinson's disease model. Oxid. Med. Cell. Long. 2019, 803. doi: 10.1155/2019/4174803

PubMed Abstract | CrossRef Full Text | Google Scholar

Hasanuzzaman, M., Nahar, K., Alam, M. M., Bhuyan, M. B., Oku, H., and Fujita, M. (2018). Exogenous nitric oxide pretreatment protects Brassica napus L. seedlings from paraquat toxicity through the modulation of antioxidant defense and glyoxalase systems. Plant Physiol. Biochem. 126, 173–186. doi: 10.1016/j.plaphy.2018.02.021

PubMed Abstract | CrossRef Full Text | Google Scholar

Huh, E., Kwon, Y., Choi, J. G., Lim, M. G., Jeong, J. S., Park, A. Y., et al. (2022). DA-9805, a Herbal mixture, restores motor manifestations in 6-hydroxydopamine-induced Parkinson's disease mouse model by regulating striatal dopamine and acetylcholine levels. Front. Pharmacol. 13, 903664. doi: 10.3389/fphar.2022.903664

PubMed Abstract | CrossRef Full Text | Google Scholar

Ishola, I. O., Akataobi, O. E., Alade, A. A., and Adeyemi, O. O. (2019). Glimepiride prevents paraquat-induced Parkinsonism in mice: involvement of oxidative stress and neuroinflammation. Fund. Clin. Pharmacol. 33, 277–285. doi: 10.1111/fcp.12434

PubMed Abstract | CrossRef Full Text | Google Scholar

Islam, M. S., Quispe, C., Hossain, R., Islam, M. T., Al-Harrasi, A., Al-Rawahi, A., et al. (2021). Neuropharmacological effects of quercetin: a literature-based review. Front. Pharmacol. 12, 665031. doi: 10.3389/fphar.2021.665031

CrossRef Full Text | Google Scholar

Jimenez-Del-Rio, M., Guzman-martinez, C., and Velez-Pardo, C. (2010). The effects of polyphenols on survival and locomotor activity in Drosophila melanogaster exposed to iron and paraquat. Neurochem. Res. 35, 227–238. doi: 10.1007/s11064-009-0046-1

PubMed Abstract | CrossRef Full Text | Google Scholar

Josiah, S. S., Famusiwa, C. D., Crown, O. O., Lawal, A. O., Olaleye, M. T., Akindahunsi, A. A., et al. (2022). Neuroprotective effects of catechin and quercetin in experimental Parkinsonism through modulation of dopamine metabolism and expression of IL-1β, TNF-α, NF-κB, IκKB, and p53 genes in male Wistar rats. Neurotoxicology 90, 158–171. doi: 10.1016/j.neuro.2022.03.004

PubMed Abstract | CrossRef Full Text | Google Scholar

Karuppagounder, S., Madathil, S., Pandey, M., Haobam, R., Rajamma, U., and Mohanakumar, K. (2013). Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson's disease in rats. J. Neurosci. 236, 136–148. doi: 10.1016/j.neuroscience.2013.01.032

PubMed Abstract | CrossRef Full Text | Google Scholar

Kejík, Z., Kaplánek, R., Masarík, M., Babula, P., Matkowski, A., Filipenský, P., et al. (2021). Iron complexes of flavonoids-antioxidant capacity and beyond. Int. J. Mol. Sci. 22, 646. doi: 10.3390/ijms22020646

PubMed Abstract | CrossRef Full Text | Google Scholar

Li, R., Wang, X., Qin, T., Qu, R., and Ma, S. (2016). Apigenin ameliorates chronic mild stress-induced depressive behavior by inhibiting interleukin-1β production and NLRP3 inflammasome activation in the rat brain. Behav. Brain Res. 296, 318–325. doi: 10.1016/j.bbr.2015.09.031

PubMed Abstract | CrossRef Full Text | Google Scholar

Li, X., Matsumoto, K., Murakami, Y., Tezuka, Y., Wu, Y., and Kadota, S. (2005). Neuroprotective effects of Polygonum multiflorum on nigrostriatal dopaminergic degeneration induced by paraquat and maneb in mice. Pharmacol. Biochem. Behav. 82, 345–352. doi: 10.1016/j.pbb.2005.09.004

PubMed Abstract | CrossRef Full Text | Google Scholar

Lima, M. M. (2013). Sleep disturbances in Parkinson's disease: the contribution of dopamine in REM sleep regulation. Sleep Med. Rev. 17, 367–375. doi: 10.1016/j.smrv.2012.10.006

PubMed Abstract | CrossRef Full Text | Google Scholar

Liou, H.-H., Chen, R.-C., Tsai, Y.-F., Chen, W.-P., Chang, Y.-C., Tsai, M.-C., et al. (1996). Effects of paraquat on the substantia nigra of the wistar rats: neurochemical, histological, and behavioral studies. Toxicol. Appl. Pharmacol. 137, 34–41. doi: 10.1006/taap.1996.0054

PubMed Abstract | CrossRef Full Text | Google Scholar

Lipski, J., Nistico, R., Berretta, N., Guatteo, E., Bernardi, G., and Mercuri, N. B. (2011). L-DOPA: a scapegoat for accelerated neurodegeneration in Parkinson's disease? Prog. Neurobiol. 94, 389–407. doi: 10.1016/j.pneurobio.2011.06.005

PubMed Abstract | CrossRef Full Text | Google Scholar

Mabandla, M. V., and Russell, V. A. (2010). Voluntary exercise reduces the neurotoxic effects of 6-hydroxydopamine in maternally separated rats. Behav. Brain Res. 211, 16–22. doi: 10.1016/j.bbr.2010.02.045

PubMed Abstract | CrossRef Full Text | Google Scholar

Manning-Bog, A. B., Mccormack, A. L., Li, J., Uversky, V. N., Fink, A. L., and Di Monte, D. A. J. (2002). The herbicide paraquat causes up-regulation and aggregation of α-synuclein in mice: paraquat and α-synuclein. J. Biol. Chem. 277, 1641–1644. doi: 10.1074/jbc.C100560200

CrossRef Full Text | Google Scholar

Meredith, G. E., and Kang, U. J. (2006). Behavioral models of Parkinson's disease in rodents: a new look at an old problem. Mov. Disord. 21, 1595–1606. doi: 10.1002/mds.21010

PubMed Abstract | CrossRef Full Text | Google Scholar

Moradi Vastegani, S., Nasrolahi, A., Ghaderi, S., Belali, R., Rashno, M., Farzaneh, M., et al. (2023). Mitochondrial dysfunction and Parkinson's disease: pathogenesis and therapeutic strategies. Neurochem. Res. 48, 2285–2308. doi: 10.1007/s11064-023-03904-0

CrossRef Full Text | Google Scholar

Moshahid Khan, M., Raza, S. S., Javed, H., Ahmad, A., Khan, A., Islam, F., et al. (2012). Rutin protects dopaminergic neurons from oxidative stress in an animal model of Parkinson's disease. Neurochem. Res. 22, 1–15. doi: 10.1007/s12640-011-9295-2

PubMed Abstract | CrossRef Full Text | Google Scholar

Nunes, R., and Carvalho, I. S. (2017). Potential application of Arbutus unedo L. leaf, fruit and flower extracts in the treatment of Alzheimer's and Parkinson's diseases. Ricardo Jorge Dos Santos Nunes 193.

Google Scholar

Onukwufor, J. O., Farooqi, M. A., Vodičková, A., Koren, S. A., Baldzizhar, A., Berry, B. J., et al. (2022). A reversible mitochondrial complex I thiol switch mediates hypoxic avoidance behavior in C. elegans. Nat. Commun. 13, 2403. doi: 10.1038/s41467-022-30169-y

CrossRef Full Text | Google Scholar

Ortiz-Ortiz, M. A., Morán, J. M., Bravosanpedro, J. M., González-Polo, R. A., Niso-Santano, M., Anantharam, V., et al. (2009). Curcumin enhances paraquat-induced apoptosis of N27 mesencephalic cells via the generation of reactive oxygen species. Neurotoxicology 30, 1008–1018. doi: 10.1016/j.neuro.2009.07.016

PubMed Abstract | CrossRef Full Text | Google Scholar

Pinheiro, J., Rodrigues, S., Mendes, S., Maranhão, P., and Ganhão, R. (2020). Impact of aqueous extract of Arbutus unedo fruits on limpets (Patella spp.) pâté during storage: proximate composition, physicochemical quality, oxidative stability, and microbial development. Foods 9, 807. doi: 10.3390/foods9060807

PubMed Abstract | CrossRef Full Text | Google Scholar

Porfírio, D. A., De Queiroz Ferreira, R., Malagutti, A. R., and Valle, E. M. (2014). Electrochemical study of the increased antioxidant capacity of flavonoids through complexation with iron (II) ions. Electrochimica 141, 33–38. doi: 10.1016/j.electacta.2014.07.046

CrossRef Full Text | Google Scholar

Ryoo, I.-G., and Kwak, M.-K. (2018). Regulatory crosstalk between the oxidative stress-related transcription factor Nfe2l2/Nrf2 and mitochondria. Toxicol. Appl. Pharmacol. 359, 24–33. doi: 10.1016/j.taap.2018.09.014

PubMed Abstract | CrossRef Full Text | Google Scholar

Sapkota, K., Kim, S., Kim, M.-K., and Kim, S.-J. (2010). A detoxified extract of rhus verniciflua stokes upregulated the expression of BDNF and GDNF in the rat brain and the human dopaminergic cell line SH-SY5Y. Biosci. Biotechnol. Biochem. 74, 1997–2004. doi: 10.1271/bbb.100165

PubMed Abstract | CrossRef Full Text | Google Scholar

See, W. Z. C., Naidu, R., and Tang, K. S. (2022). Cellular and molecular events leading to paraquat-induced apoptosis: mechanistic insights into Parkinson's disease pathophysiology. Mol. Neurobiol. 59, 3353–3369. doi: 10.1007/s12035-022-02799-2

PubMed Abstract | CrossRef Full Text | Google Scholar

Sengupta, A., Manna, K., Datta, S., Das, U., Biswas, S., Chakrabarti, N., et al. (2017). Herbicide exposure induces apoptosis, inflammation, immune modulation and suppression of cell survival mechanism in murine model. RSC Adv. 7, 13957–13970. doi: 10.1039/C6RA27883C

CrossRef Full Text | Google Scholar

Shabani, S., Rabiei, Z., and Amini-Khoei, H. J. (2020). Exploring the multifaceted neuroprotective actions of gallic acid: a review. Int. J. Food Prop. 23, 736–752. doi: 10.1080/10942912.2020.1753769

CrossRef Full Text | Google Scholar

Shahpiri, Z., Bahramsoltani, R., Hosein Farzaei, M., Farzaei, F., and Rahimi, R. (2016). Phytochemicals as future drugs for Parkinson's disease: a comprehensive review. Rev. Neurosci. 27, 651–668. doi: 10.1515/revneuro-2016-0004

CrossRef Full Text | Google Scholar

Šic Žlabur, J., Bogdanović, S., Voća, S., and Skendrović Babojelić, M. (2020). Biological potential of fruit and leaves of strawberry tree (Arbutus unedo L.) from Croatia. Molecules 25, 5102. doi: 10.3390/molecules25215102

PubMed Abstract | CrossRef Full Text | Google Scholar

Smith, Y., and Villalba, R. S. (2008). Striatal and extrastriatal dopamine in the basal ganglia: an overview of its anatomical organization in normal and Parkinsonian brains. Mov. Disord. 23, S534–S547. doi: 10.1002/mds.22027

PubMed Abstract | CrossRef Full Text | Google Scholar

Solayman, M., Islam, M. A., Alam, F., Khalil, M. I., Kamal, M. A., and Gan, S. H. (2016). Natural products combating neurodegeneration: Parkinson's disease. Curr. Drug Metab. 18, 50–61.

PubMed Abstract | Google Scholar

Somayajulu-Nitu, M., Sandhu, J. K., Cohen, J., Sikorska, M., Sridhar, T., Matei, A., et al. (2009). Paraquat induces oxidative stress, neuronal loss in substantia nigra region and Parkinsonism in adult rats: neuroprotection and amelioration of symptoms by water-soluble formulation of coenzyme Q 10. BMC Neurosci. 10, 12. doi: 10.1186/1471-2202-10-88

PubMed Abstract | CrossRef Full Text | Google Scholar

Stelmashook, E., Isaev, N., Genrikhs, E., Amelkina, G., Khaspekov, L., Skrebitsky, V., et al. (2014). Role of zinc and copper ions in the pathogenetic mechanisms of Alzheimer's and Parkinson's diseases. Biochemistry 79, 391–396. doi: 10.1134/S0006297914050022

PubMed Abstract | CrossRef Full Text | Google Scholar

Sun, J. M., Agarwal, S., Desai, T. D., Ju, D. T., Chang, Y. M., Liao, S. C., et al. (2023). Cryptotanshinone protects against oxidative stress in the paraquat-induced Parkinson's disease model. Environ. Toxicol. 38, 39–48. doi: 10.1002/tox.23660

PubMed Abstract | CrossRef Full Text | Google Scholar

Tambe, M. A., Jacquet, A. D. R., Strathearn, K. E., Yousef, G. G., Grace, M. H., Ferruzzi, M. G., et al. (2023). Protective effects of polyphenol-rich extracts against neurotoxicity elicited by paraquat or rotenone in cellular models of Parkinson's disease. bioRxiv 2023, 538474. doi: 10.1101/2023.04.26.538474

PubMed Abstract | CrossRef Full Text | Google Scholar

Tawfeek, N., Fikry, E., Mahdi, I., Ochieng, M. A., Bakrim, W. B., Taarji, N., et al. (2023). Cupressus arizonica greene: phytochemical profile and cosmeceutical and dermatological properties of its leaf extracts. Molecules 28, 1036. doi: 10.3390/molecules28031036

PubMed Abstract | CrossRef Full Text | Google Scholar

Tenuta, M. C., Deguin, B., Loizzo, M. R., Dugay, A., Acquaviva, R., Malfa, G. A., et al. (2020). Contribution of flavonoids and iridoids to the hypoglycaemic, antioxidant, and nitric oxide (NO) inhibitory activities of Arbutus unedo L. Antioxidants 9, 184. doi: 10.3390/antiox9020184

PubMed Abstract | CrossRef Full Text | Google Scholar

Tufekci, K. U., Civi Bayin, E., Genc, S., and Genc, K. (2011). The Nrf2/ARE pathway: a promising target to counteract mitochondrial dysfunction in Parkinson's disease. Parkinson's Disease 2011, 314082. doi: 10.4061/2011/314082

PubMed Abstract | CrossRef Full Text | Google Scholar

Vuuren, M. J. V., Nell, T. A., Carr, J. A., Kell, D. B., and Pretorius, E. (2020). Iron dysregulation and inflammagens related to oral and gut health are central to the development of Parkinson's disease. Biomolecules 11, 30. doi: 10.3390/biom11010030

PubMed Abstract | CrossRef Full Text | Google Scholar

Wang, X. H., Souders, I. I.C. L, Zhao, Y. H., and Martyniuk, C. J. (2018). Paraquat affects mitochondrial bioenergetics, dopamine system expression, and locomotor activity in zebrafish (Danio rerio). Chemosphere 191, 106–117. doi: 10.1016/j.chemosphere.2017.10.032

PubMed Abstract | CrossRef Full Text | Google Scholar

Wolf, A. M., Asoh, S., Hiranuma, H., Ohsawa, I., Iio, K., Satou, A., et al. (2010). Astaxanthin protects mitochondrial redox state and functional integrity against oxidative stress. J. Nutr. Biochem. 21, 381–389. doi: 10.1016/j.jnutbio.2009.01.011

PubMed Abstract | CrossRef Full Text | Google Scholar

Xiao, B., Li, Y., Lin, Y., Lin, J., Zhang, L., Wu, D., et al. (2022). Eicosapentaenoic acid (EPA) exhibits antioxidant activity via mitochondrial modulation. Food Chem. 373, 131389. doi: 10.1016/j.foodchem.2021.131389

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: Arbutus unedo L., paraquat, dopamine, redox balance, neurotoxicity

Citation: Ait Lhaj Z, Ibork H, El Idrissi S, Ait Lhaj F, Sobeh M, Mohamed WMY, Alamy M, Taghzouti K and Abboussi O (2023) Bioactive strawberry fruit (Arbutus unedo L.) extract remedies paraquat-induced neurotoxicity in the offspring prenatally exposed rats. Front. Neurosci. 17:1244603. doi: 10.3389/fnins.2023.1244603

Received: 22 June 2023; Accepted: 15 September 2023;
Published: 12 October 2023.

Edited by:

Natalia Paola Alza, National Scientific and Technical Research Council (CONICET), Argentina

Reviewed by:

Norhaizan Mohd Esa, Putra Malaysia University, Malaysia
Salim Gasmi, University of Tébessa, Algeria
Gabriela Henriquez, Seattle Children's Research Institute, United States

Copyright © 2023 Ait Lhaj, Ibork, El Idrissi, Ait Lhaj, Sobeh, Mohamed, Alamy, Taghzouti and Abboussi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Zakaria Ait Lhaj, aitlhajzakaria.smc@gmail.com; Oualid Abboussi, oualid.ab@gmail.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.